Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on STEM News Today.
Press releases published on September 2, 2025
Department of Defense (DoD) Awards Nearly $1 Million to Steadman Philippon Research Institute (SPRI) for Breakthrough Study on Extracellular Vesicles Therapeutic for Joint Regeneration
GlobeNewswire
·
September 2, 2025
VAIL, Colorado / BASALT, Colorado, Sept. 02, 2025 (GLOBE NEWSWIRE) -- The U.S. Department of Defense (DoD) has awarded a $962,977 contract to Steadman Philippon Research Institute (SPRI) to launch a year-long clinical study focused on improving therapies …
Integral Metals Announces Completion of 2025 Drilling at the KAP Project
GlobeNewswire
·
September 2, 2025
CALGARY, Alberta, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the successful completion of its 2025 diamond drilling program at the flagship KAP Project …
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
GlobeNewswire
·
September 2, 2025
ARLINGTON, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- KALA BIO, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of innovative therapies for rare and severe diseases of the eye, …
Vielight Neuro Technology Gains Traction Across Professional Sports, Powering Champions with Evidence-Backed Results
GlobeNewswire
·
September 2, 2025
Toronto, Ontario, Sept. 02, 2025 (GLOBE NEWSWIRE) -- TORONTO — Aug. 28, 2025 — Vielight, the pioneers of brain photobiomodulation (PBM) neurotechnology, is rapidly emerging as a game-changer for elite athletes. NFL and NCAA football players, Olympic …
Avaap Introduces New Program to Make it Easier for Emerging Higher Education and Government Organizations to Deploy Workday
GlobeNewswire
·
September 2, 2025
COLUMBUS, Ohio, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Avaap, a recognized leader in digital transformation for higher education, government, and nonprofit sectors, today announced the launch of Avaap One, an innovative deployment program designed to make it …
Nasus Pharma Announces Upcoming Presentation at H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
TEL AVIV, Israel, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a clinical-stage pharmaceutical company focused on the development of innovative intranasal products to treat emergency medical …
Vor Bio Appoints Adi Osovsky, S.J.D. as General Counsel
GlobeNewswire
·
September 2, 2025
CAMBRIDGE, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced the appointment of Adi Osovsky, S.J.D. as General Counsel. Dr. Osovsky …
Hopebridge Continues to Grow Autism Therapy Services in Founding State of Indiana
GlobeNewswire
·
September 2, 2025
Indianapolis, Sept. 02, 2025 (GLOBE NEWSWIRE) -- As autism spectrum disorder (ASD) diagnoses continue to rise, the demand for early identification and therapeutic intervention is greater than ever. Hopebridge Autism Therapy Centers, one of the nation’s …
Karbone Research Relaunches as Noreva: AI-Powered Market Intelligence for the Energy Transition
GlobeNewswire
·
September 2, 2025
NEW YORK, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Noreva, an AI-powered market data platform, launched today to meet the demands of the rapidly evolving energy transition. Formerly Karbone Research, Noreva is purpose-built for corporates, developers, traders, …
Opus Genetics Appoints Rob Gagnon as Chief Financial Officer
GlobeNewswire
·
September 2, 2025
RESEARCH TRIANGLE PARK, N.C., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage biopharmaceutical company developing gene therapies for inherited retinal diseases (IRDs) and small molecule therapies for other ophthalmic …
Calidi Biotherapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
SAN DIEGO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic …
4DMT Announces Leadership Expansion with Proven Late-Stage Executives to Drive 4D-150 Execution and BLA Readiness
GlobeNewswire
·
September 2, 2025
Julie Clark, M.D., promoted to Chief Medical Officer Liansheng Zhu, Ph.D., joined as SVP, Biometrics and Data Quality 4FRONT-1 Phase 3 trial enrollment continues to exceed expectations, with enrollment completion now expected in Q1 2026 Addition of …
electroCore to Participate at H.C. Wainwright Global Investment Conference
GlobeNewswire
·
September 2, 2025
ROCKAWAY, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at the H.C. Wainwright 27th Annual Global Investment …
Krystal Biotech to Present at Cantor Global Healthcare Conference 2025
GlobeNewswire
·
September 2, 2025
PITTSBURGH, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) today announced that the Company will participate in the Cantor Global Healthcare Conference 2025 on September 4, 2025, in New York. Krish S. Krishnan, …
First Set of 1-Year Clinical Results from RESOLVE Trial in Eosinophilic Esophagitis (EoE), Durable and Sustained Symptom & Tissue Responses after Dosing with EP-104GI
GlobeNewswire
·
September 2, 2025
At 12 months, 2/3rds of Cohort 5 patients (48mg dose, 4mg per site) remained in clinical remission after their treatment with EP-104GI All Cohorts followed to 9 months have maintained clinically meaningful improvements in tissue health as measured by EoE …
Lakeside Software Accelerates Growth and Innovation with Three Executive Appointments
GlobeNewswire
·
September 2, 2025
BOSTON, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Lakeside Software, the industry-leading digital employee experience company, today announced the appointment of three seasoned executives to its leadership team: Oli Giordimaina as Chief Product Officer, Brian …
vTv Therapeutics Announces $80 Million Private Placement with Leading Healthcare Institutional Investors and the T1D Fund
GlobeNewswire
·
September 2, 2025
Proceeds to fund ongoing CATT1 Phase 3 trial and continued development of cadisegliatin, a novel, potential first-in-class oral adjunctive therapy to insulin being investigated for the treatment of type 1 diabetes Topline data from CATT1 Phase 3 trial on …
Annovis to Present at the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire
·
September 2, 2025
MALVERN, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) …
Pelthos Therapeutics to Participate in the 2025 Wells Fargo Healthcare Conference
GlobeNewswire
·
September 2, 2025
DURHAM, N.C., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Pelthos Therapeutics Inc. (NYSE American: PTHS), a biopharmaceutical company (“Pelthos” or the “Company”) committed to commercializing innovative therapeutic products for high unmet patient needs, today …
Replimune Announces Type A Meeting Scheduled with FDA
GlobeNewswire
·
September 2, 2025
WOBURN, Mass., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced that a Type A meeting with the U.S. Food and Drug …